Deal Detail

Bio-Engineered Supplements and Nutrition to Glanbia plc

EV / LTM EBITDA

8.3x

EV / LTM Sales

Enterprise Value

Primary Source

Evercore

Comparable Transactions

Consumer Health transactions announced in the five years to January 2011. 2 with a disclosed multiple.

Date	Target	Acquiror	Enterprise Value	EV/Sales	EV/EBITDA	Type
Dec 2010	Maxinutrition Group Holdings Limited	GlaxoSmithKline plc	-	-	20.0x	Strategic
Jul 2010	NBTY, Inc.	The Carlyle Group L.P.	-	-	8.1x	Financial

Source-specific multiples and notes for this transaction.

Comp	Primary?	Source Type	Source	Source Advisor	Source Year	EV (USD)	EV/Sales	EV/EBITDA	EV/Fwd EBITDA	Note	Citation
	Primary	fairness opinion	NTRI FO	Evercore	2018	-	-	8.3x	-	-	Open